Novo Nordisk gatecrashes Pfizer deal with $9bn bid for Metsera
Mark Kelly, chief executive of advisory firm MKI Global Partners, said the deal had become “very...
Financial Times | AstraZeneca to elevate New York listing in blow to London
“Companies like AstraZeneca have been looking for ways to shift the balance of their listings away from London towards the USA while maintaining a guise of diplomacy.”
Recent News
Bloomberg | Pfizer Races to Save Obesity Drugmaker Deal After Novo’s Bid
Regulators could read Novo’s attempt to outbid as a strategy by a dominant player to eliminate...